XML 52 R36.htm IDEA: XBRL DOCUMENT v3.24.0.1

Accounts Payable and Accrued Liabilities (Tables)

12 Months Ended

Dec. 31, 2023

Payables and Accruals [Abstract]

Schedule of Accounts Payable and Accrued Liabilities

Accounts payable and accrued liabilities consist of the following (in thousands):

			As of December 31,
			2023						2022
Accounts payable and other accrued operating expenses			$	65,393					$	50,461
Accrued clinical trial expenses			23,711						36,456
Accrued professional fees			13,885						14,403
Accrued technical operation expenses			9,187						3,345
Accrued compensation and employee related costs			48,933						32,040
Accrued royalty and milestones payable			5,674						4,710
Accrued interest payable			2,175						6,340
Revenue Interest Payments payable			3,347						2,149
Accrued sales allowances and related costs			10,937						6,974
Accrued France ATU reimbursement payable			14,685						12,943
Deferred and contingent consideration			6,700						10,700
Other accrued liabilities			10,360						1,596
			$	214,987					$	182,117

X

- References

No definition available.

+ Details

Name:	us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the components of accrued liabilities.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration